Vanda Pharmaceuticals (VNDA) Other Working Capital Changes (2010 - 2026)

Vanda Pharmaceuticals (VNDA) has 17 years of Other Working Capital Changes data on file, last reported at $5.8 million in Q1 2026.

• For the quarter ending Q1 2026, Other Working Capital Changes rose 7.01% year-over-year to $5.8 million; the trailing twelve-month figure through Mar 2026 stood at $12.4 million (down 11.02% YoY), and the FY2025 full-year result was $12.1 million, up 77.04% from the prior year.
• Other Working Capital Changes retreated to $5.8 million in Q1 2026, from $5.9 million in the prior quarter.
• In the past five years, Other Working Capital Changes ranged from a high of $13.4 million in Q1 2022 to a low of -$11.3 million in Q1 2023.
• A 5-year average of $1.3 million and a median of $1.4 million in 2025 frame the typical range for Other Working Capital Changes.
• Peak annual rise in Other Working Capital Changes reached 26820.0% in 2022, while the deepest fall reached 398.11% in 2022.
• Tracing VNDA's Other Working Capital Changes over 5 years: stood at -$3.4 million in 2022, then sank by 108.59% to -$7.2 million in 2023, then surged by 150.58% to $3.6 million in 2024, then jumped by 63.43% to $5.9 million in 2025, then fell by 2.96% to $5.8 million in 2026.
• Business Quant data shows VNDA's Other Working Capital Changes at $5.8 million in Q1 2026, $5.9 million in Q4 2025, and -$703000.0 in Q3 2025.